US Healthcare Professionals

For adults 18 years of age and older with chronic rhinosinusitis with nasal polyps (CRSwNP) who are not adequately controlled on nasal corticosteroids.

FAQ

Frequently asked questions

Here are some answers to common questions about your chronic rhinosinusitis with nasal polyps (CRSwNP) and XOLAIR. If you still have questions after reading this, please reach out to your healthcare team.

XOLAIR and CRSwNP

Symptoms of CRSwNP can include

  • Loss of smell 
  • Runny nose
  • Postnasal drip
  • Congestion

Learn more about nasal polyps

An image of a man with nasal polyps symptoms.

Your body reacts when you come in contact with invaders, such as allergens. One way your body helps protect itself from invaders is by making a substance called IgE. In some people, the body makes too much IgE, which contributes to chronic inflammation. Chronic inflammation can lead to CRSwNP and associated symptoms.

Read about XOLAIR blocking IgE

Immunoglobulin E (IgE)

XOLAIR is an injectable prescription medicine used to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in people 18 years of age and older when medicines to treat CRSwNP called nasal corticosteroids have not worked well enough. It is not known if XOLAIR is safe and effective in people with CRSwNP under 18 years of age.

XOLAIR is not used to treat other allergic conditions, other forms of hives, or sudden breathing problems.

Learn how XOLAIR can help you

Read the Full Medication Guide for more information

XOLAIR® (omalizumab) 75mg and 150mg syringe

Not actual size

XOLAIR has been approved for another indication since 2003. XOLAIR was approved for the treatment of CRSwNP in November 2020.

Learn more about XOLAIR

Your body weight and IgE (immunoglobulin E) levels will determine how much XOLAIR you need. You may need injections every 2 weeks, or every 4 weeks.  Depending on your dose, you might need between 1 and 4 injections each time. If you gain or lose a lot of weight, your number of injections might change. Talk to your doctor.

Learn more about XOLAIR injection

In some patients, XOLAIR could be an alternative to surgery. It may also be used after you have had surgery if your CRSwNP come back.

Speak to your doctor to see if XOLAIR is right for you.

Learn more about XOLAIR

In studies, XOLAIR was proven to both

  • Reduce the number and size of stubborn nasal polyps and help free up clogged nasal passages in as little as 4 weeks*

–Up to 18% reduction compared to 2% worsening with steroid nasal spray alone

  • Rapidly clear away congestion to provide noticeable relief in as little as 4 weeks*

–Up to 38% reduction compared to 16% reduction with steroid nasal spray alone

Additionally, XOLAIR relieves symptoms that come with CRSwNP, like

  • Runny nose
  • Postnasal drip
  • Nasal congestion
  • Loss of smell

Your results may vary.

*XOLAIR was studied in 2 clinical trials with 265 adults with uncontrolled CRSwNP. Each trial lasted 24 weeks. Patients were not required to be taking oral steroids or have surgery before starting XOLAIR. XOLAIR significantly improved endoscopic, clinical, and patient-reported outcomes compared to steroid nasal sprays alone. Nasal polyp scores were measured on a severity scale of 0 to 4 for each nostril (0/best–4/worst). Congestion scores were measured on a severity scale of 0 to 3 (0/best–3/worst).

View XOLAIR's results here

Do not decrease the dose of, or stop taking any other CRSwNP medications unless otherwise instructed by your doctor. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Medication Guide

Severe allergic reaction. A severe allergic reaction called anaphylaxis can happen when you receive XOLAIR. The reaction can occur after the first dose, or after many doses. It may also occur right after a XOLAIR injection or days later. Anaphylaxis is a life-threatening condition and can lead to death. Go to the nearest emergency room right away if you have any of these symptoms of an allergic reaction:

  • Wheezing, shortness of breath, cough, chest tightness, or trouble breathing
  • Low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of “impending doom”
  • Flushing, itching, hives, or feeling warm
  • Swelling of the throat or tongue, tightness of the throat, hoarse voice, or trouble swallowing

Your healthcare provider will monitor you closely for symptoms of an allergic reaction while you are receiving XOLAIR and for a period of time after treatment is initiated. Your healthcare provider should talk to you about getting medical treatment if you have symptoms of an allergic reaction.

Do not receive XOLAIR if you are allergic to omalizumab or any of the ingredients in XOLAIR.

Click below for more Important Safety Information regarding XOLAIR.

Safety Information

  • The most common side effects of XOLAIR in adults with CRSwNP: headache, injection site reactions, joint pain, upper abdominal pain, and dizziness
  • These are not all the possible side effects of XOLAIR. Call your doctor for medical advice about side effects

Administering XOLAIR injections in the doctor's office

Once a treatment plan has been established, your doctor may decide that you may have XOLAIR administered by a nurse or doctor, or you and your doctor may decide that you can inject XOLAIR on your own, at home.

Learn more about XOLAIR injections

Self-injecting XOLAIR at home

Your doctor will determine if you or a caregiver may inject XOLAIR.

A subcutaneous injection means an injection that is given under the skin, into a person’s fat. In the doctor’s office, your doctor or nurse will inject XOLAIR into your upper arm or your thigh. After you’ve established your XOLAIR treatment in a doctor’s office or infusion center, your doctor may determine that self-injection is right for you. Your doctor may ask you about your confidence with self-injection and about your at-home support team, if you require injection assistance.

Learn more about XOLAIR injections

If you are giving the injection to your child (or another adult), you can use:

  • Front of thighs
  • Middle of thighs
  • Stomach area (abdomen). Do not inject within the 2-inch area directly around your belly button (navel)
  • Also, the outer area of the upper arms (Do not use this area if you are giving the injection to yourself.)

Learn more about XOLAIR injections

Injection self-administration site map.
Injection administration site map.

If you are giving yourself the injection, you can inject into any of these sites:

  • Front of thighs
  • Middle of thighs
  • Stomach (abdomen) – but not within the 2-inch area around the belly button (navel)

Learn more about XOLAIR self-injections

Injection administration site map.

Call your doctor’s office and ask for another training session. You can also call the XOLAIR product support line toll-free at 1-866-4XOLAIR (1-866-496-5247) if you have any questions, or click the button below.

Learn more about how to inject XOLAIR

Do not use XOLAIR if the packaging is damaged. It might not be safe to use. Call your doctor’s office for guidance. For additional information, you can also call 1-866-4XOLAIR (1-866-496-5247).

Learn more about how to inject XOLAIR

Safely throw away the prefilled syringe in a Sharps disposal container and contact your healthcare provider.

Learn more about how to inject XOLAIR

DO NOT USE the prefilled syringe if the medicine is cloudy, discolored, or contains particles. The medicine in the prefilled syringe should be clear and colorless to pale brownish-yellow. You may see an air bubble, which is normal. If the medicine does not look as described or if the expiration date has passed, safely throw away the prefilled syringe in a Sharps disposal container and contact your healthcare provider. For more information, call 1-866-4XOLAIR (1-866-496-5247).

Learn about the prefilled syringe

If the prefilled syringe does not reach room temperature, this could cause the injection to feel uncomfortable and make it hard to push the plunger.

Learn more about how to inject XOLAIR

Activating the prefilled syringe guard too early could cause that dose of XOLAIR to no longer work. The syringe guard will totally cover the needle. It is there to prevent accidental needle sticks after use. Once the guards are activated, even if the dose has not been administered, the prefilled syringe should be properly disposed of in a Sharps container. If this happens, talk to your healthcare provider.

Learn more about how to inject XOLAIR

Call your doctor to discuss when you should inject the next dose.

Learn more about how to inject XOLAIR

Dispose of used prefilled syringe immediately in a Sharps disposal container.

Learn more about how to inject XOLAIR

Prefilled syringe disposal

Store XOLAIR in your refrigerator, between 36 °F and 46 °F. DO NOT FREEZE. (Do not use if the prefilled syringe has been frozen.) Store it in the original packaging to protect it from light. Always keep your medicine out of sight and out of reach of children.

Learn more about how to inject XOLAIR

Temperature change may affect the medicine. The prefilled syringe should not be used after 48 hours at room temperature. If this happens, do not use the prefilled syringe and call your doctor’s office.

Learn more about how to inject XOLAIR

Allow about 15 to 30 minutes so the syringe can warm up to room temperature. (Leave the syringe in the box to protect it from light.)

Learn more about how to inject XOLAIR

Your local pharmacy may have a Sharps disposal container. If you cannot get one, you can use a household container that is

  • Made of a heavy-duty, leak-resistant plastic (like a laundry detergent bottle)
  • Able to be closed with a tight-fitting, puncture-resistant lid, without sharp objects being able to come out
  • Upright and stable during use

Label the container: "Hazardous waste inside"

Learn more about how to inject XOLAIR

No, XOLAIR should never be put in the freezer. It should always stay in the refrigerator until 15 to 30 minutes before you are ready to use it.

Learn more about XOLAIR injections

No, in addition to self-injection, you can have XOLAIR administered by your healthcare provider, in a healthcare setting.

Learn more about XOLAIR injections

NEXT: Downloadable Resources >

IMPORTANT SAFETY INFORMATION & INDICATION

What is XOLAIR?

XOLAIR® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat chronic rhinosinusitis with nasal polyps (CRSwNP) in people 18 years of age and older when medicines to treat CRSwNP called nasal corticosteroids have not worked well enough. It is not known if XOLAIR is safe and effective in people with CRSwNP under 18 years of age.

What is the most important information I should know about XOLAIR?

Severe allergic reaction. A severe allergic reaction called anaphylaxis can happen when you receive XOLAIR. The reaction can occur after the first dose, or after many doses. It may also occur right after a XOLAIR injection or days later. Anaphylaxis is a life-threatening condition and can lead to death. Go to the nearest emergency room right away if you have any of these symptoms of an allergic reaction:

  • wheezing, shortness of breath, cough, chest tightness, or trouble breathing
  • low blood pressure, dizziness, fainting, rapid or weak heartbeat, anxiety, or feeling of “impending doom”
  • flushing, itching, hives, or feeling warm
  • swelling of the throat or tongue, throat tightness, hoarse voice, or trouble swallowing

Your healthcare provider will monitor you closely for symptoms of an allergic reaction while you are receiving XOLAIR and for a period of time after treatment is initiated. Your healthcare provider should talk to you about getting medical treatment if you have symptoms of an allergic reaction.

Do not receive and use XOLAIR if you are allergic to omalizumab or any of the ingredients in XOLAIR.

Before receiving XOLAIR, tell your healthcare provider about all of your medical conditions, including if you:

  • have a latex allergy or any other allergies (such as food allergy or seasonal allergies). The needle cap on the XOLAIR prefilled syringe contains a type of natural rubber latex
  • have sudden breathing problems (bronchospasm)
  • have ever had a severe allergic reaction called anaphylaxis
  • have or have had a parasitic infection
  • have or have had cancer
  • are pregnant or plan to become pregnant. It is not known if XOLAIR may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if XOLAIR passes into your breast milk. Talk with your healthcare provider about the best way to feed your baby while you receive and use XOLAIR.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I receive and use XOLAIR?

  • When starting treatment XOLAIR should be given by your healthcare provider in a healthcare setting.
  • If your healthcare provider decides that you or a caregiver may be able to give your own XOLAIR prefilled syringe injections, you should receive training on the right way to prepare and inject XOLAIR.
  • Do not try to inject your XOLAIR prefilled syringe until you have been shown the right way to give XOLAIR injections by a healthcare provider. Use XOLAIR exactly as prescribed by your healthcare provider.
  • See the detailed Instructions for Use that comes with XOLAIR for information on the right way to prepare and inject XOLAIR.
  • XOLAIR is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks.
  • In people with CRSwNP, a blood test for a substance called IgE must be performed before starting XOLAIR to determine the appropriate dose and dosing frequency.
  • Do not decrease or stop taking any of your other asthma or CRSwNP medicine unless your healthcare providers tell you to.
  • You may not see improvement in your symptoms right away after XOLAIR treatment. If your asthma symptoms do not improve or get worse, call your healthcare provider.
  • If you inject more XOLAIR than prescribed, call your healthcare provider right away.

What are the possible side effects of XOLAIR?

XOLAIR may cause serious side effects, including:

  • Cancer. Cases of cancer were observed in some people who received XOLAIR.
  • Inflammation of your blood vessels. Rarely, this can happen in people with asthma who receive XOLAIR. This usually, but not always, happens in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. It is not known whether this is caused by XOLAIR. Tell your healthcare provider right away if you have rash; chest pain; shortness of breath; or a feeling of pins and needles or numbness of your arms or legs.
  • Fever, muscle aches, and rash. Some people get these symptoms 1 to 5 days after receiving a XOLAIR injection. If you have any of these symptoms, tell your healthcare provider.
  • Parasitic infection. Some people who are at a high risk for parasite (worm) infections, get a parasite infection after receiving XOLAIR. Your healthcare provider can test your stool to check if you have a parasite infection.
  • Heart and circulation problems. Some people who receive XOLAIR have had chest pain, heart attack, blood clots in the lungs or legs, or temporary symptoms of weakness on one side of the body, slurred speech, or altered vision. It is not known whether these are caused by XOLAIR.

The most common side effects of XOLAIR in adults with chronic rhinosinusitis with nasal polyps: headache, injection site reactions, joint pain, upper abdominal pain, and dizziness.

These are not all the possible side effects of XOLAIR. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555 or Novartis Pharmaceuticals Corporation at (888) 669-6682.

Please see full Prescribing Information, including Medication Guide, for additional Important Safety Information and Instructions for Use.